Key points are not available for this paper at this time.
After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups. (ClinicalTrials.gov number, NCT00002540.)
Andriole et al. (Wed,) studied this question.